148 related articles for article (PubMed ID: 23229472)
1. Consensus classification of human leukocyte antigen class II proteins.
Saha I; Mazzocco G; Plewczynski D
Immunogenetics; 2013 Feb; 65(2):97-105. PubMed ID: 23229472
[TBL] [Abstract][Full Text] [Related]
2. The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding.
Shen WJ; Zhang X; Zhang S; Liu C; Cui W
Molecules; 2018 Nov; 23(11):. PubMed ID: 30463372
[TBL] [Abstract][Full Text] [Related]
3. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.
Greenbaum J; Sidney J; Chung J; Brander C; Peters B; Sette A
Immunogenetics; 2011 Jun; 63(6):325-35. PubMed ID: 21305276
[TBL] [Abstract][Full Text] [Related]
4. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
Bordner AJ; Mittelmann HD
BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
[TBL] [Abstract][Full Text] [Related]
5. Improving the prediction of HLA class I-binding peptides using a supertype-based method.
Wang S; Bai Z; Han J; Tian Y; Shang X; Wang L; Li J; Wu Y
J Immunol Methods; 2014 Mar; 405():109-20. PubMed ID: 24508661
[TBL] [Abstract][Full Text] [Related]
6. Prediction of supertype-specific HLA class I binding peptides using support vector machines.
Zhang GL; Bozic I; Kwoh CK; August JT; Brusic V
J Immunol Methods; 2007 Mar; 320(1-2):143-54. PubMed ID: 17303158
[TBL] [Abstract][Full Text] [Related]
7. MHC2MIL: a novel multiple instance learning based method for MHC-II peptide binding prediction by considering peptide flanking region and residue positions.
Xu Y; Luo C; Qian M; Huang X; Zhu S
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S9. PubMed ID: 25521198
[TBL] [Abstract][Full Text] [Related]
8. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules.
Zhang L; Chen Y; Wong HS; Zhou S; Mamitsuka H; Zhu S
PLoS One; 2012; 7(2):e30483. PubMed ID: 22383964
[TBL] [Abstract][Full Text] [Related]
9. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
Hattotuwagama CK; Doytchinova IA; Flower DR
Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
[TBL] [Abstract][Full Text] [Related]
10. Class II HLA-peptide binding prediction using structural principles.
Mohanapriya A; Lulu S; Kayathri R; Kangueane P
Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
[TBL] [Abstract][Full Text] [Related]
11. Definition of supertypes for HLA molecules using clustering of specificity matrices.
Lund O; Nielsen M; Kesmir C; Petersen AG; Lundegaard C; Worning P; Sylvester-Hvid C; Lamberth K; Røder G; Justesen S; Buus S; Brunak S
Immunogenetics; 2004 Mar; 55(12):797-810. PubMed ID: 14963618
[TBL] [Abstract][Full Text] [Related]
12. HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.
Wang M; Larsen MV; Nielsen M; Harndahl M; Justesen S; Dziegiel MH; Buus S; Tang ST; Lund O; Claesson MH
PLoS One; 2010 May; 5(5):e10533. PubMed ID: 20479886
[TBL] [Abstract][Full Text] [Related]
13. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
14. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
[TBL] [Abstract][Full Text] [Related]
15. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
Zhao W; Sher X
PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
[TBL] [Abstract][Full Text] [Related]
16. Classification of human leukocyte antigen (HLA) supertypes.
Wang M; Claesson MH
Methods Mol Biol; 2014; 1184():309-17. PubMed ID: 25048132
[TBL] [Abstract][Full Text] [Related]
17. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
Mitić NS; Pavlović MD; Jandrlić DR
J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
[TBL] [Abstract][Full Text] [Related]
18. The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.
Jucaud V
J Immunol Res; 2017; 2017():2748614. PubMed ID: 28331856
[TBL] [Abstract][Full Text] [Related]
19. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.
Nielsen M; Lundegaard C; Blicher T; Peters B; Sette A; Justesen S; Buus S; Lund O
PLoS Comput Biol; 2008 Jul; 4(7):e1000107. PubMed ID: 18604266
[TBL] [Abstract][Full Text] [Related]
20. Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction.
Wendorff M; Garcia Alvarez HM; Østerbye T; ElAbd H; Rosati E; Degenhardt F; Buus S; Franke A; Nielsen M
Front Immunol; 2020; 11():1705. PubMed ID: 32903714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
